Rick E. Winningham - 19 Nov 2025 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Corinna Liebowitz, Attorney-in-Fact
Issuer symbol: TBPH
Transactions as of: 19 Nov 2025
Net transactions value: -$1,017,024
Form type: 4
Filing time: 21 Nov 2025, 19:10:33 UTC
Previous filing: 20 Nov 2025
Next filing: 24 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Winningham Rick E	CHIEF EXECUTIVE OFFICER, Director	C/O THERAVANCE BIOPHARMA US, LLC, 901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO	/s/ Corinna Liebowitz, Attorney-in-Fact	21 Nov 2025	0001302443

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TBPH	Ordinary Shares	Gift	$0	-9,900	-0.58%	$0.000000	1,707,886	19 Nov 2025	Direct	F1
transaction	TBPH	Ordinary Shares	Gift	$0	+9,900	+73%	$0.000000	23,400	19 Nov 2025	As Custodian	F1, F2
transaction	TBPH	Ordinary Shares	Tax liability	$1,017,024	-56,817	-3.3%	$17.90	1,651,069	20 Nov 2025	Direct	F3
holding	TBPH	Ordinary Shares						92,567	19 Nov 2025	By Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA"), for which the Reporting Person serves as a custodian.
F2	The shares are held for grandchildren of the Reporting Person through a UTMA account, for which the Reporting Person serves as custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his grandchildren's shares for purposes of Section 16 or for any other purpose.
F3	Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.